青楼妓女禁脔道具调教sm,一本加勒比HEZYO无码专区 ,国产免费一区二区三区免费视频 ,成人国产精品一区二区网站 ,久久精品成人一区二区三区

#病理分期#

5篇內(nèi)容 | 1363人圍觀

關(guān)注話題

話題活躍用戶

#插入話題

插入圖片

最新最熱

[GetTopicListResponse(id=1953666, encodeId=ec09195366696, content=<a href='/topic/show?id=ef23e10126d' target=_blank style='color:#2F92EE;'>#病理分期#</a>, objectTitle=BMC Cancer：淋巴結(jié)檢查數(shù)目（NELNs）對病理分期為 T1-3N0M0的食管鱗狀細(xì)胞癌患者預(yù)后影響, objectType=article, longId=295098, objectId=2c292950982d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2c292950982d, replyNumber=0, likeNumber=98, createdTime=2022-08-04, rootId=0, userName=ssnine, userId=25c8396, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2c292950982d, moduleTitle=BMC Cancer：淋巴結(jié)檢查數(shù)目（NELNs）對病理分期為 T1-3N0M0的食管鱗狀細(xì)胞癌患者預(yù)后影響, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=2c292950982d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1953665, encodeId=746819536658e, content=<a href='/topic/show?id=ef23e10126d' target=_blank style='color:#2F92EE;'>#病理分期#</a>, objectTitle=一文讀懂腫瘤病理分期：早/中/晚期或I/II/III/IV期, objectType=article, longId=220738, objectId=f8ef220e3862, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f8ef220e3862, replyNumber=0, likeNumber=98, createdTime=2022-04-07, rootId=0, userName=ssnine, userId=25c8396, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f8ef220e3862, moduleTitle=一文讀懂腫瘤病理分期：早/中/晚期或I/II/III/IV期, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=f8ef220e3862)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1953664, encodeId=37a3195366484, content=<a href='/topic/show?id=ef23e10126d' target=_blank style='color:#2F92EE;'>#病理分期#</a>, objectTitle=J Urol：膀胱切除術(shù)前新輔助化療對肌肉浸潤性膀胱癌的病理分期和生存預(yù)后的益處, objectType=article, longId=212006, objectId=50c321200648, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=50c321200648, replyNumber=0, likeNumber=93, createdTime=2021-12-06, rootId=0, userName=ssnine, userId=25c8396, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=50c321200648, moduleTitle=J Urol：膀胱切除術(shù)前新輔助化療對肌肉浸潤性膀胱癌的病理分期和生存預(yù)后的益處, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=50c321200648)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1953663, encodeId=73771953663df, content=<a href='/topic/show?id=ef23e10126d' target=_blank style='color:#2F92EE;'>#病理分期#</a>, objectTitle=宮頸癌FIGO2018分期：臨床分期還是手術(shù)病理分期？, objectType=article, longId=160368, objectId=4b7116036840, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4b7116036840, replyNumber=0, likeNumber=103, createdTime=2019-12-25, rootId=0, userName=ssnine, userId=25c8396, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4b7116036840, moduleTitle=宮頸癌FIGO2018分期：臨床分期還是手術(shù)病理分期？, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=4b7116036840)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1953662, encodeId=ffd8195366281, content=<a href='/topic/show?id=ef23e10126d' target=_blank style='color:#2F92EE;'>#病理分期#</a>, objectTitle=JCO：食管腺癌新輔助化療降低病理分期與生存預(yù)后密切相關(guān), objectType=article, longId=38892, objectId=e4943889206, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e4943889206, replyNumber=0, likeNumber=118, createdTime=2014-08-20, rootId=0, userName=ssnine, userId=25c8396, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e4943889206, moduleTitle=JCO：食管腺癌新輔助化療降低病理分期與生存預(yù)后密切相關(guān), moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=e4943889206)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯話題小助手

病理分期

2020-05-29

ssnine (審核中...)

前往app查看評論內(nèi)容

#病理分期#

BMC Cancer：淋巴結(jié)檢查數(shù)目（NELNs）對病理分期為 T1-3N0M0的食管鱗狀細(xì)胞癌患者預(yù)后影響

2022-08-04

ssnine (審核中...)

前往app查看評論內(nèi)容

#病理分期#

一文讀懂腫瘤病理分期：早/中/晚期或I/II/III/IV期

2022-04-07

ssnine (審核中...)

前往app查看評論內(nèi)容

#病理分期#

J Urol：膀胱切除術(shù)前新輔助化療對肌肉浸潤性膀胱癌的病理分期和生存預(yù)后的益處

2021-12-06

ssnine (審核中...)

前往app查看評論內(nèi)容

#病理分期#

宮頸癌FIGO2018分期：臨床分期還是手術(shù)病理分期？

2019-12-25

ssnine (審核中...)

前往app查看評論內(nèi)容

#病理分期#

JCO：食管腺癌新輔助化療降低病理分期與生存預(yù)后密切相關(guān)

2014-08-20

科室
- - 訂閱+
  - 更多科室
工具
服務(wù)

<ins id="umzob"><cite id="umzob"></cite></ins>

<rp id="umzob"><div id="umzob"></div></rp>

<tr id="umzob"><nobr id="umzob"></nobr></tr>